Comparative associations of traditional and new obesity framework with cardio-kidney-metabolic syndrome and all-cause mortality: a prospective cohort study
Yang Y, Liu Y, Han S, et al.
Diabetes Obes Metab. Pub. online 21 May 2026.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Screening children for early-stage type 1 diabetes
Winkler C, Friedl N, Abt R, et al.
JAMA. Pub. online 21 May 2026.
Leggi
Randomised controlled multicentre trial to investigate the effectiveness of a mobile artificial intelligence solution for diabetes adapted care: the MELISSA trial protocol
den Brok EJ, Svensson CH, Olsen MT, et al.
Diabetes Obes Metab. Pub. online 19 May 2026.
Leggi
Persistence of proinsulin-only secretion in people with long-duration diabetes and minimal residual insulin secretion
Metghalchi S, Bonnet-Serrano F, Alexandre L, et al.
Diabet Med. Pub. online 22 May 2026.
Leggi
Simplified switching to once-weekly insulin icodec without an initial one-time additional dose versus once-daily insulin glargine U100 in basal insulin-treated type 2 diabetes (ONWARDS 10): a randomised controlled trial
Rosenstock J, Mathieu C, Feinberg JBF, et al.
Diabetes Obes Metab. Pub. online 21 May 2026.
Leggi
The effects of combined antihypertensive and antidiabetic therapies on cardiovascular outcomes: a systematic review and meta-analysis
Hsieh WC, Henry BM, Édes I
Diabetes Obes Metab. Pub. online 20 May 2026.
Leggi
A systematic review and meta-analysis of the relative benefit of dual versus single oral hypoglycaemic therapy following diagnosis with type 2 diabetes (T2D)
Kelly M, Saluja S, Ellis HL, et al.
Diabet Med. Pub. online 21 May 2026.
Leggi
Team-based preconception care through collaboration between maternal-fetal medicine specialists and endocrinologists in women with diabetes
Suga S, Yasuhi I, Yamashita H, Yasui J
BMC Pregnancy Childbirth. Pub. online 23 May 2026.
Leggi
Real-world evidence of urinary tract infections and genital tract infections with sodium-glucose cotransporter-2 inhibitors (SGLT2i) alone or in combination with dipeptidyl peptidase-4 inhibitors (DPP4i) in individuals with type-2 diabetes mellitus in India
Singh NK, Singh AK, Gupta A, et al.
BMC Endocr Disord. Pub. online 20 May 2026.
Leggi
Sodium-glucose cotransporter 2 inhibitors and the risk of kidney cancer among patients with type 2 diabetes: a population-based cohort study
Lee M, Lee H, Kim EJ, et al.
BMC Med. Pub. online 12 May 2026.
Leggi